Keywords: seroquel, outdoes, risperdal, safety, says, study, studies
Seroquel outdoes Risperdal on safety, says study
Article | 05 July 2001
Studies presented at the World Congress of Biological Psychiatry inBerlin, Germany, suggest that AstraZeneca's antipsychotic drug Seroquel (quetiapine) may have ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Is the diabetes market facing a blockbuster-free future?
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
